Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Kazuya Kawai, Kōichi Nakao et al.|JAMA|2019Cited by 830
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeHirotoshi Watanabe, Motoaki Higuchi, Takeshi Morimoto et al.|JAMA Cardiology|2022Cited by 296
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresMasahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji et al.|Journal of the American Heart Association|2018Cited by 196
Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi et al.|Circulation Cardiovascular Interventions|2019Cited by 135
Long-Term Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion (from the CREDO-Kyoto Registry Cohort-2)Erika Yamamoto, Takeshi Kimura, Masahiro Natsuaki et al.|The American Journal of Cardiology|2013Cited by 82